GOFF BRIAN 1546216 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-30 | 4 | Goff Brian | CEO | dsp | 11449.0 | 44.85 | 2.06 | 28.36 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 14079.0 | 55.58 (AGIO) |
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Goff Brian | CEO | acq | 25528.0 | 100.0 | 4.59 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 25528.0 | 55.58 (AGIO) |
| 2023-08-10 | 2023-08-08 | 2023-08-08 | 4 | Goff Brian | CEO | dsp | 10178.0 | 27.68 | 1.83 | 25.48 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 26592.0 | 55.74 (AGIO) |
| 2023-08-10 | 2023-08-08 | 2023-08-08 | 4 | Goff Brian | CEO | acq | 22691.0 | 61.71 | 4.07 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 36770.0 | 55.74 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-09 | 4 | Goff Brian | CEO | dsp | 12066.0 | 23.15 | 2.16 | 22.99 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 40053.0 | 55.89 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Goff Brian | CEO | acq | 25527.0 | 48.98 | 4.57 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 52119.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-24 | 4 | Goff Brian | CEO | dsp | 7635.0 | 13.38 | 1.37 | 21.64 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 49436.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Goff Brian | CEO | acq | 17018.0 | 29.82 | 3.04 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 57071.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-05 | 4 | Goff Brian | CEO | dsp | 4156.0 | 7.17 | 0.74 | 32.57 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 53780.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Goff Brian | CEO | acq | 8500.0 | 14.67 | 1.51 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 57936.0 | 56.19 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Goff Brian | CEO | dsp | 25528.0 | 15.0 | 4.59 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 144655.0 | 55.58 (AGIO) |
| 2023-08-10 | 2023-08-08 | 2023-08-08 | 4 | Goff Brian | CEO | dsp | 22691.0 | 33.33 | 4.07 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 45382.0 | 55.74 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Goff Brian | CEO | dsp | 25527.0 | 17.65 | 4.57 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 119128.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Goff Brian | CEO | dsp | 17018.0 | 14.29 | 3.04 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 102110.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Goff Brian | CEO | dsp | 8500.0 | 33.33 | 1.51 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 17000.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Goff Brian | CEO | acq | 54000.0 | 100.0 | 9.61 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 54000.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Goff Brian | CEO | acq | 195500.0 | 100.0 | 34.79 | 32.27 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 195500.0 | 56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)